Press release

British Biotech Spots DNA Changes that Help ALS Diagnosis – Labiotech

Oxford BioDynamics Demonstrates Ability To Predict Progression Of ALS – Morningstar

Northland Capital Partners View on the City – Oxford Biodynamics PLC – Proactive Investors